New "Big Data" Brings Total Number of Breast Cancer Patients Studied to 50,000, Demonstrating Oncotype DX® Accurately Predicts Clinical Outcomes

REDWOOD CITY, Calif., Dec. 15, 2015 /PRNewswire/ — Genomic Health, Inc. (GHDX) today announced results from multiple Oncotype DX ® breast cancer test studies at the 38 th CTRC-AACR San Antonio Breast Cancer Symposium (SABCS) reconfirming that Oncotype DX …

Read more